MarketPulse

Ireland facility

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Novo Nordisk Expands Irish Plant, Elects Employee Board Representatives

Novo Nordisk elects four employee board representatives and invests €400+ million expanding Irish GLP-1 manufacturing capacity, signaling confidence in sustained demand.
NVOmanufacturing expansioncapital investment
GlobeNewswire Inc.GlobeNewswire Inc.··Novo Nordisk

Novo Nordisk Invests €432M in Irish Plant to Boost GLP-1 Drug Output

Novo Nordisk invests €432M in Irish manufacturing expansion to boost oral GLP-1 drug production capacity, targeting completion by 2028.
NVOmanufacturing expansioninvestment